Legal & General Group Plc

Position in CMPX — Compass Therapeutics, Inc.

CIK 764068 London, X0

Position in CMPX

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$397,293

+$328,810 QoQ

Shares Held

75,103

+488.9% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Legal & General Group Plc holds $3,030,824,133 across 242 Biotechnology names. CMPX ranks #141 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,955,764	$873,326,855
2	REGN	Regeneron Pharmaceuticals, Inc.	732,054	$565,614,201
3	ALNY	Alnylam Pharmaceuticals, Inc.	934,881	$309,324,075
4	RPRX	Royalty Pharma plc	3,362,872	$161,316,968
5	INCY	Incyte Corp	1,543,188	$145,244,853
6	INSM	INSMED Inc	787,079	$128,703,157
7	ARGX	Argenx SE	150,850	$110,158,211
8	MRNA	Moderna, Inc.	750,841	$38,142,721

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$397,293	75,103	+488.9%	Shares	Defined	2026-05-08
2025-12-31	$68,483	12,753	+32.3%	Shares	Defined	2026-02-09
2025-09-30	$33,750	9,643	0.0%	Shares	Defined	2025-11-13
2025-06-30	$25,071	9,643	+11.5%	Shares	Defined	2025-08-12
2025-03-31	$16,431	8,648	-15.0%	Shares	Defined	2025-05-15
2024-12-31	$14,747	10,171	0.0%	Shares	Defined	2025-02-13
2024-09-30	$18,714	10,171	+37.3%	Shares	Defined	2025-02-28
2024-06-30	$7,410	7,410	-5.8%	Shares	Defined	2025-05-29
2024-03-31	$15,576	7,867	-63.5%	Shares	Defined	2025-05-29
2023-12-31	$33,614	21,548	-54.0%	Shares	Defined	2025-05-29
2023-09-30	$92,336	46,872	-29.5%	Shares	Defined	2023-11-14
2023-06-30	$211,466	66,499	+264.0%	Shares	Defined	2023-08-14
2023-03-31	$59,736	18,268	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.